BLGO BIOLARGO INC revenue, earnings and financials
For the quarter ended June 30, 2026, BIOLARGO INC reported revenue of $1.25M (down 55.1% from a year earlier), net income of −$4.00M and diluted EPS of n/a; over the last four quarters revenue was $4.08M and net income −$18.8M; for the fiscal year ended December 2025 revenue was $7.77M, down 56.3% on the year before.
BLGO annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $7.77M, gross profit $3.41M, operating income −$14.9M, net income −$15.2M (margin -195.6%), EPS n/a
- Fiscal year ended Dec 2024: revenue $17.8M, gross profit $7.85M, operating income −$4.33M, net income −$4.35M (margin -24.5%), EPS n/a
- Fiscal year ended Dec 2023: revenue $12.2M, gross profit $6.15M, operating income −$4.58M, net income −$4.65M (margin -38.0%), EPS n/a
- Fiscal year ended Dec 2022: revenue $5.88M, gross profit $2.86M, operating income −$5.39M, net income −$5.13M (margin -87.2%), EPS n/a
- Fiscal year ended Dec 2021: revenue $2.53M, gross profit $1.10M, operating income −$6.78M, net income −$6.89M (margin -272.4%), EPS −$0.03
BLGO quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.25M (down 55.1% year over year), net income −$4.00M, EPS n/a
- Quarter ended Mar 31, 2026: revenue $1.12M (down 65.9% year over year), net income −$3.41M, EPS n/a
- Quarter ended Dec 31, 2025 (from the annual report): revenue $616K (down 83.1% year over year), net income −$4.14M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $1.10M (down 74.6% year over year), net income −$7.24M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $2.78M (down 44.6% year over year), net income −$1.88M, EPS n/a
- Quarter ended Mar 31, 2025: revenue $3.27M (down 31.3% year over year), net income −$1.92M, EPS n/a
- Quarter ended Dec 31, 2024 (from the annual report): revenue $3.65M (down 16.4% year over year), net income −$1.73M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $4.35M (up 62.8% year over year), net income −$1.06M, EPS n/a
- Quarter ended Jun 30, 2024: revenue $5.01M (up 246.7% year over year), net income −$780K, EPS n/a
- Quarter ended Mar 31, 2024: revenue $4.76M (up 27.2% year over year), net income −$775K, EPS n/a
- Quarter ended Dec 31, 2023 (from the annual report): revenue $4.37M (up 108.5% year over year), net income −$1.02M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $2.67M (up 78.1% year over year), net income −$1.51M, EPS n/a
- Quarter ended Jun 30, 2023: revenue $1.45M (up 9.3% year over year), net income −$1.63M, EPS n/a
- Quarter ended Mar 31, 2023: revenue $3.74M (up 287.8% year over year), net income −$494K, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue $2.10M (up 167.3% year over year), net income −$1.41M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $1.50M (up 110.7% year over year), net income −$847K, EPS n/a
- Quarter ended Jun 30, 2022: revenue $1.32M (up 185.1% year over year), net income −$1.33M, EPS n/a
- Quarter ended Mar 31, 2022: revenue $965K (up 69.0% year over year), net income −$1.54M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $784K, net income −$1.79M, EPS $0.00
- Quarter ended Sep 30, 2021: revenue $712K, net income −$1.44M, EPS −$0.01
BLGO cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$8.30M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$3.21M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$2.37M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$2.76M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$3.94M, share buybacks n/a
BLGO balance sheet
- Jun 30, 2026: cash $2.19M, total assets $6.67M, total liabilities $9.40M, shareholders' equity −$1.85M
- Mar 31, 2026: cash $4.12M, total assets $8.57M, total liabilities $8.75M, shareholders' equity $1.79M
- Dec 31, 2025: cash $3.88M, total assets $8.31M, total liabilities $6.79M, shareholders' equity $4.04M
- Sep 30, 2025: cash $4.55M, total assets $9.13M, total liabilities $5.92M, shareholders' equity $6.58M
- Jun 30, 2025: cash $3.47M, total assets $12.5M, total liabilities $6.44M, shareholders' equity $8.76M
- Mar 31, 2025: cash $2.56M, total assets $10.5M, total liabilities $5.42M, shareholders' equity $7.61M
- Dec 31, 2024: cash $3.55M, total assets $10.5M, total liabilities $4.46M, shareholders' equity $8.85M
- Sep 30, 2024: cash $3.88M, total assets $10.3M, total liabilities $4.32M, shareholders' equity $8.58M, long-term debt $180K
What is BLGO's revenue?
BIOLARGO INC reported $4.08M of revenue over its last four quarters, through June 30, 2026.
Is BLGO profitable?
No. BIOLARGO INC lost $18.8M over the last four quarters.